Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 154

1.

Lipoprotein(a) levels and risk of cardiovascular disease events in individuals with diabetes mellitus or prediabetes: The Atherosclerosis Risk in Communities study.

Saeed A, Sun W, Agarwala A, Virani SS, Nambi V, Coresh J, Selvin E, Boerwinkle E, Jones PH, Ballantyne CM, Hoogeveen RC.

Atherosclerosis. 2018 Dec 30;282:52-56. doi: 10.1016/j.atherosclerosis.2018.12.022. [Epub ahead of print]

PMID:
30685442
2.

Phenotype and function of HBV-specific T cells is determined by the targeted epitope in addition to the stage of infection.

Hoogeveen RC, Robidoux MP, Schwarz T, Heydmann L, Cheney JA, Kvistad D, Aneja J, Melgaço JG, Fernandes CA, Chung RT, Boonstra A, Kim AY, Baumert TF, Timm J, Lewis-Ximenez LL, Tonnerre P, Lauer GM.

Gut. 2018 Dec 22. pii: gutjnl-2018-316644. doi: 10.1136/gutjnl-2018-316644. [Epub ahead of print]

PMID:
30580250
3.

Prospective Study of Endogenous Hormones and Incidence of Venous Thromboembolism: The Atherosclerosis Risk in Communities Study.

Roetker NS, MacLehose RF, Hoogeveen RC, Ballantyne CM, Basu S, Cushman M, Folsom AR.

Thromb Haemost. 2018 Nov;118(11):1940-1950. doi: 10.1055/s-0038-1673613. Epub 2018 Oct 8.

PMID:
30296818
4.

Ambient dose during intra-oral radiography with current techniques: Part 2 quantifying the remnant beam - an in vivo study.

Hoogeveen RC, Pfältzer CC, Berkhout W.

Dentomaxillofac Radiol. 2018 Oct;47(7):20180205. doi: 10.1259/dmfr.20180205. Epub 2018 Sep 5.

PMID:
30182743
5.

Innocent Spectators, Helping Hands or a Fifth Column? Acute Hepatitis A Infection Reveals Important Insights Into Bystander T Cells.

Hoogeveen RC, Lauer GM.

Hepatology. 2018 Aug 13. doi: 10.1002/hep.30216. [Epub ahead of print] No abstract available.

PMID:
30102782
6.

Association of N-terminal pro B-type natriuretic peptide (NT-proBNP) change with the risk of atrial fibrillation in the ARIC cohort.

Li L, Selvin E, Lutsey PL, Hoogeveen RC, O'Neal WT, Soliman EZ, Chen LY, Alonso A.

Am Heart J. 2018 Oct;204:119-127. doi: 10.1016/j.ahj.2018.07.008. Epub 2018 Aug 10.

PMID:
30099337
7.

Diagnostic Performance of 1,5-Anhydroglucitol Compared to 2-H Glucose in the Atherosclerosis Risk in Communities Study.

Warren B, Lee AK, Ballantyne CM, Hoogeveen RC, Pankow JS, Grams M, Köttgen A, Selvin E.

Clin Chem. 2018 Oct;64(10):1536-1537. doi: 10.1373/clinchem.2018.291773. Epub 2018 Aug 7. No abstract available.

PMID:
30087139
8.

Ambient dose during intraoral radiography with current techniques: Part 1 conversion factor for scattered radiation using a rectangular collimator.

Hoogeveen RC, de Randamie TI, Soemodihardjo GM, Berkhout W.

Dentomaxillofac Radiol. 2018 Oct;47(7):20180108. doi: 10.1259/dmfr.20180108. Epub 2018 Sep 5.

PMID:
30028183
9.

Longitudinal increases in blood biomarkers of inflammation or cardiovascular disease and the incidence of venous thromboembolism.

Folsom AR, Lutsey PL, Heckbert SR, Poudel K, Basu S, Hoogeveen RC, Cushman M, Ballantyne CM.

J Thromb Haemost. 2018 Oct;16(10):1964-1972. doi: 10.1111/jth.14241. Epub 2018 Aug 11.

PMID:
30007116
10.

Remnant-Like Particle Cholesterol, Low-Density Lipoprotein Triglycerides, and Incident Cardiovascular Disease.

Saeed A, Feofanova EV, Yu B, Sun W, Virani SS, Nambi V, Coresh J, Guild CS, Boerwinkle E, Ballantyne CM, Hoogeveen RC.

J Am Coll Cardiol. 2018 Jul 10;72(2):156-169. doi: 10.1016/j.jacc.2018.04.050.

PMID:
29976289
11.

The Association of Biomarkers of Inflammation and Extracellular Matrix Degradation With the Risk of Abdominal Aortic Aneurysm: The ARIC Study.

Tang W, Yao L, Hoogeveen RC, Alonso A, Couper DJ, Lutsey PL, Steenson CC, Guan W, Hunter DW, Lederle FA, Folsom AR.

Angiology. 2018 Jun 26:3319718785278. doi: 10.1177/0003319718785278. [Epub ahead of print]

PMID:
29945457
12.

Traditional and nontraditional glycemic markers and risk of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) study.

Ding N, Kwak L, Ballew SH, Jaar B, Hoogeveen RC, Ballantyne CM, Sharrett AR, Folsom AR, Heiss G, Salameh M, Coresh J, Hirsch AT, Selvin E, Matsushita K.

Atherosclerosis. 2018 Jul;274:86-93. doi: 10.1016/j.atherosclerosis.2018.04.042. Epub 2018 Apr 30.

PMID:
29753232
13.

The association of mid-to late-life systemic inflammation with white matter structure in older adults: The Atherosclerosis Risk in Communities Study.

Walker KA, Windham BG, Power MC, Hoogeveen RC, Folsom AR, Ballantyne CM, Knopman DS, Selvin E, Jack CR Jr, Gottesman RF.

Neurobiol Aging. 2018 Aug;68:26-33. doi: 10.1016/j.neurobiolaging.2018.03.031. Epub 2018 Apr 4.

PMID:
29702373
14.

High-sensitivity cardiac troponin and natriuretic peptide with risk of lower-extremity peripheral artery disease: the Atherosclerosis Risk in Communities (ARIC) Study.

Matsushita K, Kwak L, Yang C, Pang Y, Ballew SH, Sang Y, Hoogeveen RC, Jaar BG, Selvin E, Ballantyne CM, Sharrett AR, Folsom AR, Heiss G, Coresh J, Hirsch AT.

Eur Heart J. 2018 Jul 1;39(25):2412-2419. doi: 10.1093/eurheartj/ehy106.

PMID:
29579246
15.

A prospective study of soluble receptor for advanced glycation end products and adipokines in association with pancreatic cancer in postmenopausal women.

White DL, Hoogeveen RC, Chen L, Richardson P, Ravishankar M, Shah P, Tinker L, Rohan T, Whitsel EA, El-Serag HB, Jiao L.

Cancer Med. 2018 May;7(5):2180-2191. doi: 10.1002/cam4.1426. Epub 2018 Mar 23.

16.

Usefulness of Lipoprotein-Associated Phospholipase A2 Activity and C-Reactive Protein in Identifying High-Risk Smokers for Atherosclerotic Cardiovascular Disease (from the Atherosclerosis Risk in Communities Study).

Tibuakuu M, Kianoush S, DeFilippis AP, McEvoy JW, Zhao D, Guallar E, Ballantyne CM, Hoogeveen RC, Blaha MJ, Michos ED.

Am J Cardiol. 2018 May 1;121(9):1056-1064. doi: 10.1016/j.amjcard.2018.01.020. Epub 2018 Feb 6.

PMID:
29525060
17.

Relation of Lifestyle Factors and Life's Simple 7 Score to Temporal Reduction in Troponin Levels Measured by a High-Sensitivity Assay (from the Atherosclerosis Risk in Communities Study).

Fretz A, McEvoy JW, Rebholz CM, Ndumele CE, Florido R, Hoogeveen RC, Ballantyne CM, Selvin E.

Am J Cardiol. 2018 Feb 15;121(4):430-436. doi: 10.1016/j.amjcard.2017.11.017. Epub 2017 Nov 24.

18.

Associations of Lipoprotein(a) Levels With Incident Atrial Fibrillation and Ischemic Stroke: The ARIC (Atherosclerosis Risk in Communities) Study.

Aronis KN, Zhao D, Hoogeveen RC, Alonso A, Ballantyne CM, Guallar E, Jones SR, Martin SS, Nazarian S, Steffen BT, Virani SS, Michos ED.

J Am Heart Assoc. 2017 Dec 15;6(12). pii: e007372. doi: 10.1161/JAHA.117.007372.

19.

Lipoprotein-associated phospholipase A2 and risk of incident peripheral arterial disease: Findings from The Atherosclerosis Risk in Communities study (ARIC).

Garg PK, Norby FL, Polfus LM, Boerwinkle E, Gibbs RA, Grove ML, Folsom AR, Garimella PS, Matsushita K, Hoogeveen RC, Ballantyne CM.

Atherosclerosis. 2018 Jan;268:12-18. doi: 10.1016/j.atherosclerosis.2017.11.007. Epub 2017 Nov 14.

PMID:
29169030
20.

Galectin-3 and Venous Thromboembolism Incidence: the Atherosclerosis Risk in Communities (ARIC) Study.

Fashanu OE, Heckbert SR, Aguilar D, Jensen PN, Ballantyne CM, Basu S, Hoogeveen RC, deFilippi C, Cushman M, Folsom AR.

Res Pract Thromb Haemost. 2017 Oct;1(2):223-230. doi: 10.1002/rth2.12038. Epub 2017 Sep 4.

21.

Midlife Systemic Inflammation, Late-Life White Matter Integrity, and Cerebral Small Vessel Disease: The Atherosclerosis Risk in Communities Study.

Walker KA, Power MC, Hoogeveen RC, Folsom AR, Ballantyne CM, Knopman DS, Windham BG, Selvin E, Jack CR Jr, Gottesman RF.

Stroke. 2017 Dec;48(12):3196-3202. doi: 10.1161/STROKEAHA.117.018675. Epub 2017 Nov 3.

22.

Midlife systemic inflammatory markers are associated with late-life brain volume: The ARIC study.

Walker KA, Hoogeveen RC, Folsom AR, Ballantyne CM, Knopman DS, Windham BG, Jack CR Jr, Gottesman RF.

Neurology. 2017 Nov 28;89(22):2262-2270. doi: 10.1212/WNL.0000000000004688. Epub 2017 Nov 1.

23.

Galectin-3 and incidence of atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study.

Fashanu OE, Norby FL, Aguilar D, Ballantyne CM, Hoogeveen RC, Chen LY, Soliman EZ, Alonso A, Folsom AR.

Am Heart J. 2017 Oct;192:19-25. doi: 10.1016/j.ahj.2017.07.001. Epub 2017 Jul 8.

24.

Plasma galectin-3 levels are associated with the risk of incident chronic kidney disease.

Rebholz CM, Selvin E, Liang M, Ballantyne CM, Hoogeveen RC, Aguilar D, McEvoy JW, Grams ME, Coresh J.

Kidney Int. 2018 Jan;93(1):252-259. doi: 10.1016/j.kint.2017.06.028. Epub 2017 Aug 31.

25.

Association of High-Density Lipoprotein-Cholesterol Versus Apolipoprotein A-I With Risk of Coronary Heart Disease: The European Prospective Investigation Into Cancer-Norfolk Prospective Population Study, the Atherosclerosis Risk in Communities Study, and the Women's Health Study.

van Capelleveen JC, Bochem AE, Boekholdt SM, Mora S, Hoogeveen RC, Ballantyne CM, Ridker PM, Sun W, Barter PJ, Tall AR, Zwinderman AH, Kastelein JJP, Wareham NJ, Khaw KT, Hovingh GK.

J Am Heart Assoc. 2017 Aug 3;6(8). pii: e006636. doi: 10.1161/JAHA.117.006636.

26.

Hepatitis B virus infection and the immune response: The big questions.

Boeijen LL, Hoogeveen RC, Boonstra A, Lauer GM.

Best Pract Res Clin Gastroenterol. 2017 Jun;31(3):265-272. doi: 10.1016/j.bpg.2017.05.003. Epub 2017 May 22. Review.

PMID:
28774408
27.

Lipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURN.

Puri R, Ballantyne CM, Hoogeveen RC, Shao M, Barter P, Libby P, Chapman MJ, Erbel R, Arsenault BJ, Raichlen JS, Nissen SE, Nicholls SJ.

Atherosclerosis. 2017 Aug;263:137-144. doi: 10.1016/j.atherosclerosis.2017.06.026. Epub 2017 Jun 15.

PMID:
28641153
28.

The association of lipoprotein(a) with incident heart failure hospitalization: Atherosclerosis Risk in Communities study.

Agarwala A, Pokharel Y, Saeed A, Sun W, Virani SS, Nambi V, Ndumele C, Shahar E, Heiss G, Boerwinkle E, Konety S, Hoogeveen RC, Ballantyne CM.

Atherosclerosis. 2017 Jul;262:131-137. doi: 10.1016/j.atherosclerosis.2017.05.014. Epub 2017 May 12.

29.

Circulating ceruloplasmin, ceruloplasmin-associated genes, and the incidence of atrial fibrillation in the atherosclerosis risk in communities study.

Arenas de Larriva AP, Norby FL, Chen LY, Soliman EZ, Hoogeveen RC, Arking DE, Loehr LR, Alonso A.

Int J Cardiol. 2017 Aug 15;241:223-228. doi: 10.1016/j.ijcard.2017.04.005. Epub 2017 Apr 6.

30.

Detection of genetic loci associated with plasma fetuin-A: a meta-analysis of genome-wide association studies from the CHARGE Consortium.

Jensen MK, Jensen RA, Mukamal KJ, Guo X, Yao J, Sun Q, Cornelis M, Liu Y, Chen MH, Kizer JR, Djoussé L, Siscovick DS, Psaty BM, Zmuda JM, Rotter JI, Garcia M, Harris T, Chen I, Goodarzi MO, Nalls MA, Keller M, Arnold AM, Newman AB, Hoogeveen RC, Rexrode KM, Rimm EB, Hu FB, Ramachandran VS, Katz R, Pankow JS, Ix JH.

Hum Mol Genet. 2017 Jun 1;26(11):2156-2163. doi: 10.1093/hmg/ddx091.

31.

Postprandial lipemia and the risk of coronary heart disease and stroke: the Atherosclerosis Risk in Communities (ARIC) Study.

Kats D, Sharrett AR, Ginsberg HN, Nambi V, Ballantyne CM, Hoogeveen RC, Heiss G.

BMJ Open Diabetes Res Care. 2017 Feb 1;5(1):e000335. doi: 10.1136/bmjdrc-2016-000335. eCollection 2017.

32.

Myocardial Injury, Obesity, and the Obesity Paradox: The ARIC Study.

Pokharel Y, Sun W, Virani SS, Nambi V, Hoogeveen RC, Chang PP, Ndumele CE, Solomon SD, Bozkurt B, Selvin E, Ballantyne CM, Deswal A.

JACC Heart Fail. 2017 Jan;5(1):56-63. doi: 10.1016/j.jchf.2016.10.010. Epub 2016 Dec 21.

33.

Association between high-sensitivity troponin T and cardiovascular risk in individuals with and without metabolic syndrome: The ARIC study.

Pokharel Y, Sun W, Villareal DT, Selvin E, Virani SS, Ndumele CE, Hoogeveen RC, Coresh J, Boerwinkle E, Butler KR, Solomon SD, Pankow JS, Bozkurt B, Ballantyne CM, Nambi V.

Eur J Prev Cardiol. 2017 Apr;24(6):628-638. doi: 10.1177/2047487316683071. Epub 2016 Dec 12.

34.

Postprandial Monocyte Activation in Individuals With Metabolic Syndrome.

Khan IM, Pokharel Y, Dadu RT, Lewis DE, Hoogeveen RC, Wu H, Ballantyne CM.

J Clin Endocrinol Metab. 2016 Nov;101(11):4195-4204. Epub 2016 Aug 30.

35.

Biomarkers and degree of atherosclerosis are independently associated with incident atherosclerotic cardiovascular disease in a primary prevention cohort: The ARIC study.

Agarwala A, Virani S, Couper D, Chambless L, Boerwinkle E, Astor BC, Hoogeveen RC, Coresh J, Sharrett AR, Folsom AR, Mosley T, Ballantyne CM, Nambi V.

Atherosclerosis. 2016 Oct;253:156-163. doi: 10.1016/j.atherosclerosis.2016.08.028. Epub 2016 Aug 25.

36.

Severe Hypoglycemia and Elevated High-Sensitivity Cardiac Troponin T in Older Adults With Diabetes: The ARIC Study.

Lee AK, McEvoy JW, Hoogeveen RC, Ballantyne CM, Selvin E.

J Am Coll Cardiol. 2016 Sep 20;68(12):1370-1. doi: 10.1016/j.jacc.2016.06.049. No abstract available.

37.

Diastolic Blood Pressure, Subclinical Myocardial Damage, and Cardiac Events: Implications for Blood Pressure Control.

McEvoy JW, Chen Y, Rawlings A, Hoogeveen RC, Ballantyne CM, Blumenthal RS, Coresh J, Selvin E.

J Am Coll Cardiol. 2016 Oct 18;68(16):1713-1722. doi: 10.1016/j.jacc.2016.07.754. Epub 2016 Aug 30.

38.

A genetic risk score is associated with statin-induced low-density lipoprotein cholesterol lowering.

Leusink M, Maitland-van der Zee AH, Ding B, Drenos F, van Iperen EP, Warren HR, Caulfield MJ, Cupples LA, Cushman M, Hingorani AD, Hoogeveen RC, Hovingh GK, Kumari M, Lange LA, Munroe PB, Nyberg F, Schreiner PJ, Sivapalaratnam S, de Bakker PI, de Boer A, Keating BJ, Asselbergs FW, Onland-Moret NC.

Pharmacogenomics. 2016 Apr;17(6):583-91. doi: 10.2217/pgs.16.8. Epub 2016 Apr 5.

39.

The value of thyroid shielding in intraoral radiography.

Hoogeveen RC, Hazenoot B, Sanderink GC, Berkhout WE.

Dentomaxillofac Radiol. 2016;45(5):20150407. doi: 10.1259/dmfr.20150407. Epub 2016 Mar 23.

40.

Plasma Levels of Endothelial Microparticles Bearing Monomeric C-reactive Protein are Increased in Peripheral Artery Disease.

Crawford JR, Trial J, Nambi V, Hoogeveen RC, Taffet GE, Entman ML.

J Cardiovasc Transl Res. 2016 Jun;9(3):184-93. doi: 10.1007/s12265-016-9678-0. Epub 2016 Feb 18.

41.

Assessment of Random Error in Phantom Dosimetry with the Use of Error Simulation in Statistical Software.

Hoogeveen RC, Martens EP, van der Stelt PF, Berkhout WE.

Biomed Res Int. 2015;2015:596858. doi: 10.1155/2015/596858. Epub 2015 Dec 31.

42.

Causal Role of Alcohol Consumption in an Improved Lipid Profile: The Atherosclerosis Risk in Communities (ARIC) Study.

Vu KN, Ballantyne CM, Hoogeveen RC, Nambi V, Volcik KA, Boerwinkle E, Morrison AC.

PLoS One. 2016 Feb 5;11(2):e0148765. doi: 10.1371/journal.pone.0148765. eCollection 2016.

43.

Soluble receptor for advanced glycation end products and the risk for incident heart failure: The Atherosclerosis Risk in Communities Study.

Lazo M, Halushka MK, Shen L, Maruthur N, Rebholz CM, Rawlings AM, Hoogeveen RC, Brinkley TE, Ballantyne CM, Astor BC, Selvin E.

Am Heart J. 2015 Nov;170(5):961-7. doi: 10.1016/j.ahj.2015.08.008. Epub 2015 Aug 14.

44.

GCKR and PPP1R3B identified as genome-wide significant loci for plasma lactate: the Atherosclerosis Risk in Communities (ARIC) study.

Tin A, Balakrishnan P, Beaty TH, Boerwinkle E, Hoogeveen RC, Young JH, Kao WH.

Diabet Med. 2016 Jul;33(7):968-75. doi: 10.1111/dme.12971. Epub 2015 Oct 30.

45.

Carboxymethyl lysine, an advanced glycation end product, and incident diabetes: a case-cohort analysis of the ARIC Study.

Luft VC, Duncan BB, Schmidt MI, Chambless LE, Pankow JS, Hoogeveen RC, Couper DJ, Heiss G.

Diabet Med. 2016 Oct;33(10):1392-8. doi: 10.1111/dme.12963. Epub 2015 Oct 6.

46.

Complex interventions for preventing diabetic foot ulceration.

Hoogeveen RC, Dorresteijn JA, Kriegsman DM, Valk GD.

Cochrane Database Syst Rev. 2015 Aug 24;(8):CD007610. doi: 10.1002/14651858.CD007610.pub3. Review.

PMID:
26299991
48.

[Radiobiological aspects of diagnostic X-ray use in dentistry].

Hoogeveen RC, van den Aardweg GJ.

Ned Tijdschr Tandheelkd. 2015 May;122(5):287-92. doi: 10.5177/ntvt.2015.05.14223. Review. Dutch.

PMID:
26210221
49.

Reducing an already low dental diagnostic X-ray dose: does it make sense? Comparison of three cost-utility analysis methods used to assess two dental dose-reduction measures.

Hoogeveen RC, Sanderink GC, van der Stelt PF, Berkhout WE.

Dentomaxillofac Radiol. 2015;44(9):20150158. doi: 10.1259/dmfr.20150158. Epub 2015 Jul 24.

50.

Lipoprotein associated phospholipase A2 activity, apolipoprotein C3 loss-of-function variants and cardiovascular disease: The Atherosclerosis Risk In Communities Study.

Pokharel Y, Sun W, Polfus LM, Folsom AR, Heiss G, Sharrett AR, Boerwinkle E, Ballantyne CM, Hoogeveen RC.

Atherosclerosis. 2015 Aug;241(2):641-8. doi: 10.1016/j.atherosclerosis.2015.06.033. Epub 2015 Jun 18.

Supplemental Content

Loading ...
Support Center